EP2279007
Pegýleruð raðbrigða manna vaxtarhormónssambönd
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.4.2009EP published:
18.5.2016EP application number:
09738181.8
EP translation filed:
8.8.2016Grant published:
15.9.2016EPO information:
European Patent Register
Max expiry date:
28.4.2029Expiry date:
28.4.2026Next due date:
30.4.2026
Title:
PEGYLATED RECOMBINANT HUMAN GROWTH HORMONE COMPOUNDS
Timeline
Today
29.4.2009EP application
18.5.2016EP Publication
8.8.2016Translation submitted
15.9.2016Registration published
28.4.2026Expires
Owner
Name:
Ascendis Pharma Endocrinology Division A/SAddress:
c/o Ascendic Pharma A/S, Tuborg Boulevard 5, 2900, Hellerup, DK
Inventor
Name:
RAU, HaraldAddress:
Dossenheim, DE
Name:
KINDERMANN, SusanneAddress:
Liestal, CH
Name:
LESSMANN, TorbenAddress:
Neustadt an der Weinstraße, DE
Name:
RASMUSSEN, Grethe NørskovAddress:
Farum, DK
Name:
HERSEL, UlrichAddress:
Heidelberg, DE
Name:
WEGGE, ThomasAddress:
Heidelberg, DE
Name:
SPROGØE, KennettAddress:
Palo Alto CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
08155408Date:
29.4.2008Country:
EP
Number:
08162865Date:
22.8.2008Country:
EP
Number:
08167289Date:
22.10.2008Country:
EP
Classification
Categories:
A61K 47/48, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 21.4.2017
Expires: 28.4.2018
Payer: Guðjón Styrkársson, hrl.
Number: 10
Paid: 20.4.2018
Expires: 28.4.2019
Payer: Guðjón Styrkársson, hrl.
Number: 11
Paid: 15.4.2019
Expires: 28.4.2020
Payer: Guðjón Styrkársson, hrl.
Number: 12
Paid: 27.4.2020
Expires: 28.4.2021
Payer: Patice ehf.
Number: 13
Paid: 19.4.2021
Expires: 28.4.2022
Payer: Patice ehf.
Number: 14
Paid: 13.4.2022
Expires: 28.4.2023
Payer: Patice ehf.
Number: 15
Paid: 22.4.2023
Expires: 28.4.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 26.4.2024
Expires: 28.4.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 23.4.2025
Expires: 28.4.2026
Payer: Árnason Faktor ehf.